Analysts fell to the sidelines weighing in on Accenture (ACN – Research Report), AeroVironment (AVAV – Research Report) and Paychex (PAYX – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Accenture (ACN)
Robert W. Baird analyst David Koning maintained a Hold rating on Accenture on June 27 and set a price target of $310.00. The company’s shares closed last Wednesday at $279.81, close to its 52-week low of $268.17.
According to TipRanks.com, Koning is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Accenture with a $346.13 average price target, implying a 24.3% upside from current levels. In a report released yesterday, BNP Paribas also downgraded the stock to Hold with a $320.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
AeroVironment (AVAV)
Robert W. Baird analyst Peter Arment maintained a Hold rating on AeroVironment yesterday and set a price target of $95.00. The company’s shares closed last Wednesday at $77.96.
According to TipRanks.com, Arment is a 4-star analyst with an average return of
AeroVironment has an analyst consensus of Moderate Buy, with a price target consensus of $95.00.
Paychex (PAYX)
In a report issued on June 27, Mark Marcon from Robert W. Baird maintained a Hold rating on Paychex, with a price target of $142.00. The company’s shares closed last Wednesday at $114.85.
According to TipRanks.com, Marcon is a 5-star analyst with an average return of
Paychex has an analyst consensus of Hold, with a price target consensus of $131.50, implying a 13.2% upside from current levels. In a report released yesterday, Evercore ISI also maintained a Hold rating on the stock with a $116.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ACN:
- Doximity (DOCS) Gets a Buy Rating from Robert W. Baird
- Robert W. Baird Keeps a Buy Rating on Visa (V)
- Thor Industries (THO) Receives a Buy from Robert W. Baird
- Robert W. Baird Maintains a Buy Rating on Griffon (GFF)
- Analysts Offer Insights on Healthcare Companies: Arbutus Biopharma (ABUS) and Decibel Therapeutics (DBTX)
